Prostate cancer Is one of the leading causes of cancer-related deaths for m
en in the United States. Like other malignancies, prostate cancer is unders
cored by a variety of aberrant genetic alterations during its development.
Although loss of heterozygosity or allelic loss is frequently Identified am
ong prostate cancers, few genes have been identified thus far as critical t
o the development of invasive prostate cancers. in this report, we used the
recently developed technology, the "differential subtraction chain," to pe
rform a genome-wide search for sequences that are deleted in an aggressive
prostate cancer. Among the deleted sequences, we found that one sequence wa
s deleted in > 50% of prostate cancers we tested. We mapped this sequence t
o chromosome 4q25 by screening the Genebridge 4 hamster radiation panel wit
h primers specific to this probe, and subsequently identify a 54-kb minimal
common deletion region that contains the sequence encoding myopodin. Seque
nce analysis indicates that myopodin shares significant homology with synap
topodin, a protein closely associated with podocyte and neuron differentiat
ion. Further study shows that frequent complete or partial deletions of the
myopodin gene occurred among invasive prostate cancer cases (25 of 31 case
s, or 80%). Statistical analysis indicates that deletion of myopodin is hig
hly correlated with the invasiveness of prostate cancers, and thus may hold
promise as an important prognostic marker for prostate cancers.